Assessment of added activity of an antitumor agent
Year: 2022
Type: article
Source: Contemporary Clinical Trials
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W4308060356
